Literature DB >> 15649251

Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the alpha1,2-fucosyltransferase gene.

Masao Iwamori1, Kyoko Tanaka, Kaneyuki Kubushiro, Bei Lin, Kazushige Kiguchi, Isamu Ishiwata, Katsumi Tsukazaki, Shiro Nozawa.   

Abstract

Transfection of the mouse Fut1 and Fut2, and human FUT1 genes into human ovarian carcinoma-derived RMG-1 cells resulted in 20-30-fold increases in cellular alpha1,2-fucosyltransferase activity, and in alteration of the glycolipid composition, including not only fucosylated products, but also precursor glycolipids. Although globo-series glycolipids were not significantly affected by the transfection, the major glycolipids belonging to the lacto-series type 1 chain family in RMG-1 cells and the transfectants were the Lc4Cer, Lewis a (Le)a and Leb, and H-1 glycolipids, respectively, suggesting that fucosylation of Lc4Cer to the H-1 glycolipid prevents the further modification of Lc4Cer to Lea and Leb in the transfectants. Also, the lacto-series type 2 chains in RMG-1 cells were LeX, NeuAc-nLc4Cer and NeuAc-LeX, and those in the transfectants were LeX and LeY, indicating that the sialylation of nLc4Cer and LeX is restricted by increased fucosylation of LeX. As a result, the amount of sialic acid released by sialidase from the transfectants decreased to 70% of that from RMG-1 cells, and several membrane-mediated phenomena, such as the cell-to-cell interaction between cancer cells and mesothelial cells, and the cell viability in the presence of an anticancer drug, 5-fluorouracil, for the transfectants was found to be increased in comparison to that for RMG-1 cells. These findings indicate that cell surface carbohydrates are involved in the biological properties, including cell-to-cell adhesion and drug resistance, of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649251     DOI: 10.1111/j.1349-7006.2005.00005.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  31 in total

1.  Enhanced expression of unique gangliosides with GM2-determinant in human uterine cervical carcinoma-derived cell lines.

Authors:  Kyoko Tanaka; Masaki Miyazawa; Mikio Mikami; Daisuke Aoki; Kazushige Kiguchi; Masao Iwamori
Journal:  Glycoconj J       Date:  2016-06-06       Impact factor: 2.916

2.  Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.

Authors:  Lian-Cheng Zhu; Jian Gao; Zhen-Hua Hu; Carlton L Schwab; Hui-Yu Zhuang; Ming-Zi Tan; Li-Mei Yan; Juan-Juan Liu; Dan-Ye Zhang; Bei Lin
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

3.  Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells.

Authors:  Song Gao; Liancheng Zhu; Huilin Feng; Zhenhua Hu; Shan Jin; Zuofei Song; Dawo Liu; Juanjuan Liu; Yingying Hao; Xiao Li; Bei Lin
Journal:  Tumour Biol       Date:  2016-05-30

4.  Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.

Authors:  Jian Gao; Zhenhua Hu; Juanjuan Liu; Dawo Liu; Yanyan Wang; Mingbo Cai; Danye Zhang; Mingzi Tan; Bei Lin
Journal:  Med Oncol       Date:  2014-04-02       Impact factor: 3.064

5.  Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells.

Authors:  Kyoko Tanaka; Kazushige Kiguchi; Mikio Mikami; Daisuke Aoki; Masao Iwamori
Journal:  Hum Cell       Date:  2019-07-26       Impact factor: 4.174

6.  Expression of α2,6-sialic acid-containing and Lewis-active glycolipids in several types of human ovarian carcinomas.

Authors:  Kyoko Tanaka; Mikio Mikami; Daisuke Aoki; Kazushige Kiguchi; Isamu Ishiwata; Masao Iwamori
Journal:  Oncol Lett       Date:  2010-09-09       Impact factor: 2.967

7.  The emerging importance of α-L-fucose in human breast cancer: a review.

Authors:  Jay J Listinsky; Gene P Siegal; Catherine M Listinsky
Journal:  Am J Transl Res       Date:  2011-07-20       Impact factor: 4.060

8.  Effects of Lewis Y antigen on the gene expression of multiple drug resistance-associated proteins in human ovarian cancer RMG-I-H cells.

Authors:  Song Gao; Qing Liu; Xinyan Wang; Bei Lin; Shulan Zhang
Journal:  Med Oncol       Date:  2009-09-23       Impact factor: 3.064

9.  Lewis Y promotes growth and adhesion of ovarian carcinoma-derived RMG-I cells by upregulating growth factors.

Authors:  Feifei Li; Bei Lin; Yingying Hao; Yan Li; Juanjuan Liu; Jianping Cong; Liancheng Zhu; Qing Liu; Shulan Zhang
Journal:  Int J Mol Sci       Date:  2010-09-29       Impact factor: 5.923

10.  Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.

Authors:  Juanjuan Liu; Bei Lin; Yingying Hao; Yue Qi; Liancheng Zhu; Feifei Li; Dawo Liu; Jianping Cong; Shulan Zhang; Masao Iwamori
Journal:  J Exp Clin Cancer Res       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.